Gene · 23705
Papers3,480
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 3,480
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| An antibody-drug conjugate for endometrioid carcinoma based on the expression of cell adhesion molecule 1. | Mol Cell Oncol | 2024 | 39252827 | PubTator, text mining | PubMed |
| Single-cell sequencing reveals glial cell involvement in development of neuropathic pain via myelin sheath lesion formation in the spinal cord. | J Neuroinflammation | 2024 | 39217340 | PubTator, text mining | PubMed |
| A complex of the lipid transport ER proteins TMEM24 and C2CD2 with band 4.1 at cell-cell contacts. | J Cell Biol | 2024 | 39158698 | PubTator, text mining | PubMed |
| The Potential of Single-Chain Variable Fragment Antibody: Role in Future Therapeutic and Diagnostic Biologics. | J Immunol Res | 2024 | 39156005 | PubTator, text mining | PubMed |
| Anti-tumor effect of antibody-drug conjugate targeting cell adhesion molecule 1 on GIST cells representing small intestinal GIST. | Exp Mol Pathol | 2024 | 39096891 | PubTator, text mining | PubMed |
| Overexpression of EGFL7 promotes angiogenesis and nerve regeneration in peripheral nerve injury. | Cell Biol Int | 2024 | 39080995 | PubTator, text mining | PubMed |
| Three candidate SNPs show associations with thyroid-stimulating hormone in euthyroid subjects: Tehran thyroid study. | J Diabetes Metab Disord | 2024 | 38932823 | PubTator, text mining | PubMed |
Performance of CADM1, MAL and miR124-2 methylation as triage markers for early detection of cervical cancer in self-collected and clinician-collected samples: an exploratory observational study in Papua New Guinea. | BMJ Open | 2024 | 38904134 | PubTator, text mining | PubMed |
| Molecular landscape of borderline ovarian tumours: A systematic review. | Open Med (Wars) | 2024 | 38859878 | PubTator, text mining | PubMed |
| Flow cytometric profiles with CD7 and CADM1 in CD4+ T cells are promising indicators for prognosis of aggressive ATL. | Blood Adv | 2024 | 38820467 | PubTator, text mining | PubMed |
| Advancements in clinical RNA therapeutics: Present developments and prospective outlooks. | Cell Rep Med | 2024 | 38744276 | PubTator, text mining | PubMed |
| Determination of target genes for classified molecular subtypes of triple-negative breast cancer form microarray gene expression profiling: An integrative in silico approach. | Indian J Pathol Microbiol | 2024 | 38718221 | PubTator, text mining | PubMed |
| Engineering pluripotent stem cells with synthetic biology for regenerative medicine. | Med Rev (2021) | 2024 | 38680679 | PubTator, text mining | PubMed |
| Chemical Space Profiling of SARS-CoV-2 PLpro Using DNA-Encoded Focused Libraries. | ACS Med Chem Lett | 2024 | 38628804 | PubTator, text mining | PubMed |
| MicroRNA-155-3p Promotes Breast Cancer Progression Through Down-Regulating CADM1 [Retraction]. | Onco Targets Ther | 2024 | 38601331 | PubTator, text mining | PubMed |
| Retraction: "Downregulation of microRNA-205 inhibits cell invasion and angiogenesis of cervical cancer through TSLC1-mediated Akt signaling pathway". | J Cell Physiol | 2024 | 38591643 | PubTator, text mining | PubMed |
| Skeletal stem cells in bone development, homeostasis, and disease. | Protein Cell | 2024 | 38442300 | PubTator, text mining | PubMed |
| Prognostic Markers in Tyrosine Kinases Specific to Basal-like 2 Subtype of Triple-Negative Breast Cancer. | Int J Mol Sci | 2024 | 38338684 | PubTator, text mining | PubMed |
| Exploring the frontiers: tumor immune microenvironment and immunotherapy in head and neck squamous cell carcinoma. | Discov Oncol | 2024 | 38294629 | PubTator, text mining | PubMed |
| The role and mechanism of RIPK1 in vascular endothelial dysfunction in chronic kidney disease. | FASEB J | 2024 | 38275125 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/23705/papers?page=7